IMAGE: The Journal publishes original scientific papers, reviews, and case studies on a broad spectrum of topics in lactation therapy. It showcases evidence-based research advances and examines perspective … immediate and long-term more
Credit: Mary Ann Liebert, Inc., publishers
New Rochelle, NY, January 12, 2021 – The Academy of Breastfeeding Medicine (ABM) is not proposing to discontinue breast milk for individuals receiving the COVID-19 vaccine. In a new statement, the ABM recommends that women who are lactating talk about the risks and benefits of vaccination with their healthcare provider, within the risk of getting a contract from COVID-19 and developing a serious illness, according to the peer-reviewed journal Breastfeeding therapy. Click here to read the ABM statement now.
This is a challenging topic because the vaccine trials excluded women who ate lactate. Therefore, there are no clinical data on the safety of the Pfizer / BioNtech vaccine or the Moderna vaccine in nursing mothers. According to the ABM report, “there is little biological plausibility that the vaccine will cause harm, and antibodies to SARS-CoV-2 [the virus that causes COVID-19] in milk it may protect the breastfed baby. “
“Without clinical data, the Academy of Breastfeeding Medicine relied on biological plausibility and expert opinion to report consideration for COVID-19 mRNA vaccines in lactation,” said Alison Stuebe, MD, President ABM. “The information available is encouraging; however, pregnant or lactating people are more than credible for guiding medical decisions. Therefore, level 3 clinical trials should be include pregnant or lactating partners on a regular basis. It’s time to protect pregnant or breastfeeding people through research, not research. “
Arthur I. Eidelman, MD, Managing Editor Breastfeeding therapy, says: “The publication of the ABM statement will be fair as an immediate guide for clinicians and families in deciding to proceed with Covid-19 vaccination of nursing mothers.”
###
In Iris
Breastfeeding therapy, the official journal of the Breastfeeding Academy of Medicine, is an authoritative, peer – reviewed journal, published 10 times a year in print and online. The Journal publishes original scientific papers, reviews, and case studies on a broad spectrum of topics in lactation therapy. It showcases evidence-based research advances and examines immediate and long-term outcomes of breast milk, including breastfeeding epidemiologic, physiologic, and psychological benefits. Table of contents and sample case can be viewed on the Breastfeeding therapy website.
About the Breastfeeding Medicine Academy
The Breastfeeding Academy of Medicine is a worldwide organization of medical doctors dedicated to the promotion, protection and support of breastfeeding. Our mission is to unite members of the various medical experts with this common purpose. For more than 20 years, ABM has been bringing doctors together to provide evidence-based solutions to the challenges facing breastfeeding worldwide. A large body of research has revealed important nutritional, psychological and psychological benefits to mothers and children who survive well beyond childhood. But while breastfeeding is fundamental to life and health, clinical practice lags behind scientific evidence. By building on our research legacy in this area and sharing it with the wider medical community, we can overcome barriers, influence health policies, and change behavior.
About the publisher
Mary Ann Liebert Publishers, Inc., is renowned for establishing peer-reviewed authoritative journals in many promising areas of biomedical science and research. A full list of the 90 magazines, books, and news magazines can be found on the website of Mary Ann Liebert, Inc. publishers.
Disclaimer: AAAS and EurekAlert! they are not responsible for the accuracy of press releases posted to EurekAlert! by sending institutions or for using any information through the EurekAlert system.